Zydus Lifesciences, Lupin recall products in US market owing to manufacturing issues

Zydus initiated the Class II voluntary recall on July 15 this year. Similarly, Baltimore-based Lupin Pharmaceuticals, Inc, is recalling 7,872 bottles of Rifampin Capsules, a medication used to treat infections caused by bacteria.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/RuAwZxK
via IFTTT